These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 19699923)

  • 41. Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival.
    Borst GR; De Jaeger K; Belderbos JS; Burgers SA; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):639-44. PubMed ID: 15936539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of a treatment strategy for optimising preoperative chemoradiotherapy in stage III non-small-cell lung cancer.
    Phernambucq EC; Spoelstra FO; Paul MA; Senan S; Melissant CF; Postmus PE; Smit EF
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):1052-7. PubMed ID: 19616442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.
    Giorgio CG; Pappalardo A; Russo A; Santini D; Di Rosa C; Di Salvo C; Castorina S; Marletta F; Bellissima G; Palermo N; Scuderi C; Bordonaro R
    Anticancer Drugs; 2007 Jul; 18(6):713-9. PubMed ID: 17762402
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
    Langer CJ; Movsas B; Hudes R; Schol J; Keenan E; Kilpatrick D; Yeung C; Curran W
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: the Cancer and Leukemia Group B (CALGB) 9335, a phase II, multi-institutional cooperative group study.
    Shennib H; Bogart J; Herndon JE; Kohman L; Keenan R; Green M; Sugarbaker D; ;
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):813-8. PubMed ID: 15821648
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Neoadjuvant combined therapy in stage IIIA if non-small-cell bronchial cancer].
    Thomas M; Rübe C; Semik M; Junker K; von Eiff M
    Dtsch Med Wochenschr; 1997 Aug; 122(33):993-8. PubMed ID: 9296933
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of combined radiation, paclitaxel and carboplatin for locally advanced non-small cell lung carcinoma.
    Nguyen NP; Leonardo JM; Karlsson U; Vos P; Bullock L; Thomas P; Lepera P; Ludin A; Chu C; Salehpour M; Jendrasiak G; Sallah S
    Anticancer Res; 2002; 22(6B):3429-35. PubMed ID: 12552935
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Obesity does not increase complications after anatomic resection for non-small cell lung cancer.
    Smith PW; Wang H; Gazoni LM; Shen KR; Daniel TM; Jones DR
    Ann Thorac Surg; 2007 Oct; 84(4):1098-105; discussion 1105-6. PubMed ID: 17888954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer.
    Belani CP; Wang W; Johnson DH; Wagner H; Schiller J; Veeder M; Mehta M;
    J Clin Oncol; 2005 Jun; 23(16):3760-7. PubMed ID: 15837967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial.
    Pallarés C; Capdevila J; Paredes A; Farré N; Ciria JP; Membrive I; Basterrechea L; Gomez-Segura G; Barnadas A
    Lung Cancer; 2007 Nov; 58(2):238-45. PubMed ID: 17658655
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preoperative pulmonary function as a prognostic factor for stage I non-small cell lung carcinoma.
    Iizasa T; Suzuki M; Yasufuku K; Iyoda A; Otsuji M; Yoshida S; Sekine Y; Shibuya K; Saitoh Y; Hiroshima K; Fujisawa T
    Ann Thorac Surg; 2004 Jun; 77(6):1896-902; discussion 1902-3. PubMed ID: 15172232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of preoperative body mass index on respiratory complications after pneumonectomy for non-small-cell lung cancer. Results from a series of 154 consecutive standard pneumonectomies.
    Petrella F; Radice D; Borri A; Galetta D; Gasparri R; Solli P; Veronesi G; Spaggiari L
    Eur J Cardiothorac Surg; 2011 May; 39(5):738-44. PubMed ID: 20952203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thoracoscopic lobectomy: a safe and effective strategy for patients receiving induction therapy for non-small cell lung cancer.
    Petersen RP; Pham D; Toloza EM; Burfeind WR; Harpole DH; Hanish SI; D'Amico TA
    Ann Thorac Surg; 2006 Jul; 82(1):214-8; discussion 219. PubMed ID: 16798217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Additional pulmonary resections after pneumonectomy: actual long-term survival and functional results.
    Grodzki T; Alchimowicz J; Kozak A; Kubisa B; Pieróg J; Wójcik J; Bielewicz M; Witkowska D
    Eur J Cardiothorac Surg; 2008 Sep; 34(3):493-8. PubMed ID: 18583143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of neoadjuvant chemotherapy on pulmonary structures: a quantitative analysis.
    Ceylan KC; Kaya SO; Samancilar O; Gursoy S; Ucvet A
    Thorac Cardiovasc Surg; 2012 Mar; 60(2):111-5. PubMed ID: 21512976
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A clinical prediction rule for pulmonary complications after thoracic surgery for primary lung cancer.
    Amar D; Munoz D; Shi W; Zhang H; Thaler HT
    Anesth Analg; 2010 May; 110(5):1343-8. PubMed ID: 19861366
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Persistent N2 disease after neoadjuvant chemotherapy for non-small-cell lung cancer.
    Higgins KA; Chino JP; Ready N; Onaitis MW; Berry MF; D'Amico TA; Kelsey CR
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1175-9. PubMed ID: 22014344
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of lung function changes after induction radiochemotherapy on resected T4 non-small cell lung cancer outcome.
    Perentes J; Bopp S; Krueger T; Gonzalez M; Jayet PY; Lovis A; Matzinger O; Ruffieux C; Ris HB; Letovanec I; Peters S
    Ann Thorac Surg; 2012 Dec; 94(6):1815-22. PubMed ID: 23103000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pulmonary function tests as a predictor of quantitative and qualitative outcomes after thoracic surgery for lung cancer.
    Greillier L; Thomas P; Loundou A; Doddoli C; Badier M; Auquier P; Barlési F
    Clin Lung Cancer; 2007 Nov; 8(9):554-61. PubMed ID: 18186960
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sleeve lobectomy after induction chemoradiotherapy.
    Gómez-Caro A; Boada M; Reguart N; Viñolas N; Casas F; Molins L
    Eur J Cardiothorac Surg; 2012 May; 41(5):1052-8. PubMed ID: 22223693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.